###begin article-title 0
Syndecan-1 and FGF-2, but Not FGF Receptor-1, Share a Common Transport Route and Co-Localize with Heparanase in the Nuclei of Mesenchymal Tumor Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: KD. Performed the experiments: FZ EF NW PH CM GN. Analyzed the data: FZ KD. Contributed reagents/materials/analysis tools: FZ IK LS KD. Wrote the paper: FZ NW KD. Designed the constructs: LS. Critically revised the paper: IK LS GT. Revised the paper: PH GN KD.
###end p 1
###begin p 2
Syndecan-1 forms complexes with growth factors and their cognate receptors in the cell membrane. We have previously reported a tubulin-mediated translocation of syndecan-1 to the nucleus. The transport route and functional significance of nuclear syndecan-1 is still incompletely understood. Here we investigate the sub-cellular distribution of syndecan-1, FGF-2, FGFR-1 and heparanase in malignant mesenchymal tumor cells, and explore the possibility of their coordinated translocation to the nucleus. To elucidate a structural requirement for this nuclear transport, we have transfected cells with a syndecan-1/EGFP construct or with a short truncated version containing only the tubulin binding RMKKK sequence. The sub-cellular distribution of the EGFP fusion proteins was monitored by fluorescence microscopy. Our data indicate that syndecan-1, FGF-2 and heparanase co-localize in the nucleus, whereas FGFR-1 is enriched mainly in the perinuclear area. Overexpression of syndecan-1 results in increased nuclear accumulation of FGF-2, demonstrating the functional importance of syndecan-1 for this nuclear transport. Interestingly, exogenously added FGF-2 does not follow the route taken by endogenous FGF-2. Furthermore, we prove that the RMKKK sequence of syndecan-1 is necessary and sufficient for nuclear translocation, acting as a nuclear localization signal, and the Arginine residue is vital for this localization. We conclude that syndecan-1 and FGF-2, but not FGFR-1 share a common transport route and co-localize with heparanase in the nucleus, and this transport is mediated by the RMKKK motif in syndecan-1. Our study opens a new perspective in the proteoglycan field and provides more evidence of nuclear interactions of syndecan-1.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 376 379 376 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Tumova1">[1]</xref>
###xml 381 384 381 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Bernfield1">[2]</xref>
###xml 485 488 485 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Tkachenko1">[3]</xref>
###xml 490 493 490 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Beauvais1">[4]</xref>
###xml 683 686 683 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Elenius1">[5]</xref>
###xml 957 960 957 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Rapraeger1">[6]</xref>
###xml 962 965 962 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-SpivakKroizman1">[7]</xref>
###xml 967 970 967 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Rahmoune1">[8]</xref>
###xml 972 975 972 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Schlessinger1">[9]</xref>
###xml 977 981 977 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Yayon1">[10]</xref>
Proteoglycans (PGs) are highly sulfated macromolecules, whose protein cores bear covalently attached glycosaminoglycan (GAG) chains. Cell surface heparan sulfate proteoglycans (HSPGs) are present in most cells of both vertebrates and invertebrates. At the cell surface the GAG chains interact with many ligands such as growth factors (GFs), cytokines, adhesion molecules etc. [1], [2], and they are essential modulators of cellular signaling in embryonic development and tumorigenesis [3], [4]. The transmembrane HSPG syndecan-1 is the prototype member of the syndecan family, and it participates in assembling signaling complexes by presenting GFs to growth factor receptors (GFRs) [5]. The ability of basic fibroblast growth factor (FGF-2) to bind to fibroblast growth factor receptor-1 (FGFR-1) has been proven to depend largely on the presence of heparan sulfate (HS), which interacts with both FGF-2 and FGFR-1, stabilizing the ligand/receptor complex [6], [7], [8], [9], [10].
###end p 4
###begin p 5
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Ilan1">[11]</xref>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Liu1">[12]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-GingisVelitski1">[13]</xref>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Reiland1">[14]</xref>
The HS chains can be degraded by heparanase through enzymatic cleavage [11] and in this way the HSPG-bound GFs can be liberated. Experimental studies show that cleavage of the HS chain may generate oligosaccharide sequences, which can either inhibit or potentiate the effect of the GFs [12]. Notably, HS is not only a substrate for, but also a regulator of heparanase uptake [13], and syndecan-1 in turn is able to regulate the biological activity of heparanase [14].
###end p 5
###begin p 6
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Brockstedt1">[15]</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Brockstedt1">[15]</xref>
###xml 753 757 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Pillai1">[16]</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Ishihara1">[17]</xref>
###xml 765 769 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Fedarko1">[18]</xref>
###xml 771 775 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Cheng1">[19]</xref>
###xml 847 851 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Richardson1">[20]</xref>
###xml 869 873 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Leadbeater1">[21]</xref>
###xml 875 879 875 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Schrage1">[22]</xref>
###xml 895 899 895 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Liang1">[23]</xref>
Traditionally, syndecan-1 has been thought to exert its effect in signaling at the level of the cell membrane. However, we have previously shown a regulated nuclear translocation and co-localization of syndecan-1 with tubulin in the mitotic spindle [15]. We detected prominent nuclear syndecan-1 not only in malignant mesothelioma but also in various adenocarcinomas and in neuroblastoma cells. Similar but weaker nuclear staining was seen in different benign cells of mesenchymal origin [15]. This was the first evidence for the nuclear translocation of the whole syndecan-1 molecule. The HS chains of PGs have long been known to be present in the nuclear compartment of various normal and transformed cells concurrently with inhibition of cell growth [16], [17], [18], [19]. Apart from syndecan-1, other HSPGs can also be present in the nucleus [20], e.g. syndecan-2 [21], [22] and glypican-1 [23].
###end p 6
###begin p 7
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Roghani1">[24]</xref>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Joy1">[25]</xref>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Maher1">[26]</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Stachowiak1">[27]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Wiedlocha1">[28]</xref>
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Bonnet1">[29]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Baldin1">[30]</xref>
###xml 579 583 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Kilkenny1">[31]</xref>
###xml 685 689 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Malecki1">[32]</xref>
The route and functional significance of this nuclear transport of syndecan-1 is still incompletely understood. Mounting evidence suggests a similar nuclear accumulation of GFs [24], [25], and their receptors [26], [27], [28]. Exogenously added FGF-2 has been shown to internalize and translocate to the nucleus in proliferating cells, whereas in quiescent cells it remains mainly cytoplasmic [29]. The nuclear and nucleolar translocation of FGF-2 and FGFR-1 occurs around the restriction point of the cell cycle in mid-late G1 phase, suggesting a controlled nuclear entry [30], [31]. Moreover, the efficiency of the nuclear FGF-2 translocation is increased in the presence of heparin [32].
###end p 7
###begin p 8
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Brockstedt1">[15]</xref>
In our previous work, double staining experiments clearly demonstrated that syndecan-1 is structurally linked to the intracellular microtubule system in all phases of cell division, and that inhibition of microtubule polymerization by vinblastine treatment hampers the nuclear translocation of syndecan-1 [15]. As syndecan-1 can bind both GFs and their GFRs, we aimed in this study to investigate the possibility of a regulated co-translocation of syndecan-1, FGF-2 and FGFR-1. Furthermore, we hypothesize that the syndecan-1/tubulin complex may not only act as a vehicle for the transport of GFs to the cell nucleus, but it may also constitute a functional entity in an intracrine route, which operates independently from the cell surface receptor function. Our experiments are designed to clarify the translocation of the syndecan-1/FGF-2/FGFR-1 complex, and the structural requirement for the nuclear transport of syndecan-1.
###end p 8
###begin title 9
Materials and Methods
###end title 9
###begin title 10
Cell lines and cell culture conditions
###end title 10
###begin p 11
###xml 474 478 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Klominek1">[33]</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Thurzo1">[34]</xref>
###xml 669 670 656 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 746 747 733 734 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 895 899 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Dobra1">[35]</xref>
###xml 948 952 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Zong1">[36]</xref>
###xml 271 276 <span type="species:ncbi:9606">human</span>
###xml 392 398 <span type="species:ncbi:9913">bovine</span>
###xml 418 422 <span type="species:ncbi:9913">calf</span>
###xml 489 494 <span type="species:ncbi:9606">human</span>
Three cell lines of mesenchymal origin were used in this study. The STAV malignant mesothelioma cells were generally grown in RPMI 1640 medium containing 25 mM HEPES (GIBCO, Grand Island, NY, USA) and 2 mM L-Glutamine. The STAV-AB cell sub-line was supplemented with 10% human AB serum and displayed epithelial differentiation, while the STAV-FCS cell sub-line was supplemented with 5% fetal bovine serum (FBS) and 5% calf serum (CS) to achieve a fibroblast-like morphology [33]. The B6FS human fibrosarcoma cells [34] were grown in RPMI 1640 + GlutaMAXtrade mark-1 (GIBCO) supplemented with 10% FBS and 20 microg/ml Gentamicin (GIBCO). All cells were cultured in 75 cm2 Tissue Culture Flasks (Sarstedt, Newton, NC, USA) in humidified 5% (v/v) CO2 at 37degreesC and culture medium was changed twice a week. The STAV-AB cells show a low endogenous syndecan-1 expression level on the cell surface [35], while the B6FS cells do not express syndecan-1 [36].
###end p 11
###begin title 12
Sub-cellular localization of syndecan-1, endogenous FGF-2, heparanase and FGFR-1
###end title 12
###begin p 13
The sub-cellular distributions of syndecan-1, heparanase, FGF-2 and FGFR-1 were examined by immunocytochemical analysis and subsequent confocal laser microscopy. Cells were seeded onto Superfrost Plus microscope slides and allowed to adhere for 6-48 hours before they were fixed with 3% paraformaldehyde at 37degreesC for 10 minutes, and then permeabilized with 0.1-0.5% Triton X-100 (Sigma, Steinheim, Germany) at 37degreesC for 15 minutes. For the tubulin depolymerization experiments, cells were fixed in ice-cold methanol for 10 minutes, rehydrated in PBS and taken directly for immunocytochemistry.
###end p 13
###begin p 14
###xml 292 299 292 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007346-t001">Table 1</xref>
###xml 448 455 442 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007346-t002">Table 2</xref>
###xml 192 196 <span type="species:ncbi:9925">goat</span>
For visualization of cell membrane syndecan-1 and HS reactivity, the cells were not permeabilized in order to keep the integrity of the cell membrane. Non-specific binding was blocked with 3% goat serum (DAKO A/S, Giostrup, Denmark) for 30 minutes; thereafter the primary antibody was added (Table 1). Slides were incubated overnight in a humidified chamber at 4degreesC, followed by 30 minutes of incubation with fluorescent secondary antibodies (Table 2) in darkness at room temperature. The slides were counterstained with 1 mg/L Bisbenzimide H33342 (FLUKA, Steinheim, Germany), and mounted in DAKO Fluorescent Mounting Medium (DAKO, Via Real Carpiteria, CA, USA).
###end p 14
###begin title 15
Primary antibodies used.
###end title 15
###begin title 16
Secondary antibodies used.
###end title 16
###begin p 17
###xml 35 39 <span type="species:ncbi:9925">goat</span>
###xml 43 49 <span type="species:ncbi:9793">donkey</span>
Blocking solutions consisted of 3% goat or donkey serum, or 1% BSA in PBS.
###end p 17
###begin p 18
###xml 175 182 175 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007346-t001">Table 1</xref>
###xml 156 161 <span type="species:ncbi:10090">mouse</span>
###xml 165 169 <span type="species:ncbi:9925">goat</span>
Double labeling was performed by simultaneous incubation with the respective primary antibodies. Negative controls were used, either with affinity purified mouse or goat IgG (Table 1) or, in the case of CD138, by preincubating the antibody with the syndecan-1 epitope.
###end p 18
###begin p 19
A large number of primary and secondary antibody combinations were tested and the corresponding isotype controls were always included to allow background subtraction. We performed single label experiments to exclude over-bleeding between the channels.
###end p 19
###begin title 20
Nuclear complex co-immunoprecipitation and immunoblotting
###end title 20
###begin p 21
###xml 448 454 <span type="species:ncbi:9913">bovine</span>
###xml 565 569 <span type="species:ncbi:9925">goat</span>
###xml 1320 1325 <span type="species:ncbi:10090">mouse</span>
###xml 1331 1336 <span type="species:ncbi:9606">human</span>
###xml 1473 1478 <span type="species:ncbi:10090">mouse</span>
Nuclear complex co-immunoprecipitation (Co-IP) was carried out using the Nuclear Complex Co-IP Kit (Active Motif Europe, Rixensart, Belgium) according to the manufacturer's instructions. Briefly, nuclear extracts of sub-confluent cells were prepared 24-36 hours after seeding of cells stably transfected with syndecan-1/EGFP constructs or those transfected with just EGFP vector. Protein concentrations were determined by the Bradford method using bovine serum albumin (BSA) as a standard. For Co-IP, 100 microg of each nuclear extract was reacted with 3 microg of goat polyclonal antibody against the C-terminus of syndecan-1 (C-20, sc-7099, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). The coupled protein/antibody complexes were adsorbed onto protein G Sepharosetrade mark Fast Flow beads (GE Healthcare Life Sciences, Uppsala, Sweden). The protein/antibody complex beads were re-suspended in TBS buffer. The immunoprecipitated proteins were released from the beads by boiling at 95-100degreesC for 3-5 minutes and spinning briefly to collect supernatants. The nuclear precipitates from equal amounts of control and sample proteins were blotted directly to a nitrocellulose membrane, using the Minifold II Slot Blot System (Schleicher & Schuell, Inc., Keene, NH, USA.), and followed by immunoblotting with a mouse anti-human FGF-2 monoclonal antibody (MCA1400G, AbD Serotec Ltd., Oxford, UK). The secondary antibody was an ECLtrade mark Peroxidase-labeled anti-mouse antibody (NA931VS, GE Healthcare Life Sciences, Uppsala, Sweden). Chemiluminescence detection was performed using Western Lightening trade mark Chemiluminescence Reagent Plus (NEL 104, Perkin Elmer LAS, Inc., Waltham,,MA, USA). Chemiluminescence signals were recorded with a charge-coupled device camera (FluorChem(R)SP, AlphaInnotech, San Leandro, CA, USA).
###end p 21
###begin title 22
Confocal laser microscopy
###end title 22
###begin p 23
For detailed visualization of the distribution of antibody reactivity, confocal laser microscopy was used. This was performed with a Leica TCS NT confocal laser scanning microscope equipped with an ArKr laser, permitting the detection of signals from the fluorochromes with emission wavelengths at 488 nm and 568 nm. Scanning was performed using a 63x1.2 NA objective lens and higher magnifications with zoom function. Images were obtained by scanning in the XY direction with a focal depth of 0.3 microm and were then processed with Adobe Photoshop software. For each experiment the excitation and sensitivity of the detector were adjusted so that the signals were normalized to the corresponding negative controls. The instrument settings were adjusted to omit non-specific reactivity and over-bleeding.
###end p 23
###begin title 24
Effect of drugs interfering with microtubule assembly and cell cycle progression on the sub-cellular distribution of syndecan-1, FGF-2 and FGFR-1
###end title 24
###begin p 25
###xml 324 328 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Akner1">[37]</xref>
###xml 588 589 582 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 943 944 937 938 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 520 525 <span type="species:ncbi:10090">mouse</span>
###xml 555 559 <span type="species:ncbi:9925">goat</span>
###xml 565 570 <span type="species:ncbi:10090">mouse</span>
###xml 612 616 <span type="species:ncbi:9925">goat</span>
###xml 641 647 <span type="species:ncbi:9793">donkey</span>
###xml 653 657 <span type="species:ncbi:9925">goat</span>
###xml 695 699 <span type="species:ncbi:9925">goat</span>
###xml 724 730 <span type="species:ncbi:9793">donkey</span>
###xml 736 740 <span type="species:ncbi:9925">goat</span>
###xml 811 816 <span type="species:ncbi:10090">mouse</span>
###xml 845 849 <span type="species:ncbi:9925">goat</span>
###xml 855 860 <span type="species:ncbi:10090">mouse</span>
###xml 889 894 <span type="species:ncbi:10090">mouse</span>
###xml 924 928 <span type="species:ncbi:9925">goat</span>
###xml 934 939 <span type="species:ncbi:10090">mouse</span>
Vinblastine promotes depolymerization of tubulin and its redistribution into paracrystalline inclusion bodies. To depolymerize tubulin structures, cells were exposed to 10 microM of vinblastine (Velbe(R) - Eli Lilly Sweden AB, Stockholm, Sweden) for 2 hours, as an established way to demonstrate tubulin-dependent transport [37]. This was followed by immunocytochemical staining for FGF-2, syndecan-1 (CD 138) and FGFR-1. All experiments were performed in at least triplicate. Double staining was performed for tubulin (mouse monoclonal IgG1, detected by goat anti-mouse IgG (H+L), F(ab')2 Alexa 488) and FGF-2 (goat polyclonal, detected by donkey anti-goat IgG (H+L) Alexa 568), or syndecan-1 (goat polyclonal, detected by donkey anti-goat IgG (H+L) Alexa 568). Double staining was also performed with FGFR-1 (mouse monoclonal IgM, detected by goat anti-mouse IgM Alexa 488) and tubulin (mouse monoclonal IgG1, detected by goat anti-mouse IgG1 Alexa 568).
###end p 25
###begin p 26
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Xiao1">[38]</xref>
###xml 623 624 617 618 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 536 541 <span type="species:ncbi:10090">mouse</span>
###xml 590 594 <span type="species:ncbi:9925">goat</span>
###xml 600 605 <span type="species:ncbi:10090">mouse</span>
Doxorubicin is a chemotherapeutic agent known to cause cellular damage via a number of mechanisms including inhibition of topoisomerase II, nucleotide intercalation, free radical formation and inhibition of DNA replication. Doxorubicin treatment results in G2 arrest and interferes with cell cycle progression by sustaining the G2 arrest after DNA damage [38]. Mesothelioma cells were exposed to 1.2 microg/ml Doxorubicin (Adriamycin(R), Pharmacia & Upjohn, Stockholm, Sweden) for 48 hours, followed by immunocytochemical staining with mouse monoclonal IgG1 against syndecan-1, detected by goat anti-mouse IgG (H+L), F(ab')2 Alexa 488.
###end p 26
###begin title 27
Sub-cellular localization of exogenously added FGF-2 in the mesothelioma cells
###end title 27
###begin p 28
###xml 84 92 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 740 741 738 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 123 128 <span type="species:ncbi:9606">human</span>
###xml 578 582 <span type="species:ncbi:9925">goat</span>
###xml 607 613 <span type="species:ncbi:9793">donkey</span>
###xml 619 623 <span type="species:ncbi:9925">goat</span>
###xml 671 676 <span type="species:ncbi:10090">mouse</span>
###xml 707 711 <span type="species:ncbi:9925">goat</span>
###xml 717 722 <span type="species:ncbi:10090">mouse</span>
The sub-cellular fate of exogenously added, fluorescence-tagged FGF-2 was monitored in vitro. For this purpose recombinant human FGF-2 (R&D Systems, Minneapolis, MN, USA) was labeled with Alexa Fluor(R) 488 (A10235, Molecular Probes, Inc., Leiden, The Netherlands), according to the instructions of the manufacturers. Based on our previous data on the mitogenic effect of FGF-2 on mesothelioma cells, the concentration of FGF-2 used ranged from 5-50 ng/mL. The observation times were 16 h, 24 h and 42 h after seeding. In parallel, double staining was performed for syndecan-1 (goat polyclonal, detected by donkey anti-goat IgG (H+L) Alexa 568) and the endogenous FGF-2 (mouse monoclonal IgG2a, detected by goat anti-mouse IgG (H+L), F(ab')2 Alexa 488).
###end p 28
###begin title 29
Transfection of cells with full-length and truncated syndecan-1 constructs and detection of nuclear accumulation of syndecan-1
###end title 29
###begin p 30
###xml 704 711 704 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 476 481 <span type="species:ncbi:9606">human</span>
###xml 704 711 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
To further clarify the possible role of syndecan-1, we have transfected the cells with a syndecan-1/EGFP construct, or a truncated variant, coding only for the RMKKK sequence, which corresponds to a hypothesized nuclear localization signal of syndecan-1. The syndecan-1/EGFP constructs were prepared by Szilak Labor Ltd, (Szeged, Hungary) and the pEGFP-N1 vector, used as a negative control, was purchased from BD Biosciences, (Clontech, Palo Alto, CA, USA). The construct of human syndecan-1 was cloned on a HindIII - BamHI fragment into pEGFP-N1 plasmid in-frame with the N-terminal end of EGFP. The correct DNA sequence of this construct was verified by DNA sequencing. The plasmids were amplified in E. coli and purified with EndoFree Plasmid Maxi Kit (QIAGEN GmbH, Hilden, Germany). Their purity was determined by spectrophotometry and agarose gel electrophoresis.
###end p 30
###begin p 31
###xml 231 232 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 609 614 <span type="species:ncbi:10090">mouse</span>
Cells were transfected with the constructs above, using Effectene Transfection Reagent (QIAGEN GmbH, Hilden, Germany). Optimization of the transfection was carried out according to the manufacturer's guidelines. Briefly, about 2x105 cells were seeded into 6-well plates and incubated for 24 hours to reach 40-80% of confluence at the time of transfection. Transient transfections were performed using 0.4 microg DNA and a DNA/Effectene ratio of 1:25. The presence of the functional syndecan-1/EGFP fusion protein was verified by immunocytochemical analysis with antibodies against syndecan-1 (CD-138) and HS (mouse monoclonal IgM, clone 10E4, Seikagaku Corporation, Tokyo, Japan) using confocal microscopy, as described above. The appearance and sub-cellular distribution of the newly synthesized syndecan-1 were evaluated at various time points (6, 12, 24, 48, and 72 hours) after transfection using a fluorescence microscope (Leica DM IRBE, Openlab 3.0.4 software) to follow the EGFP-positive cells.
###end p 31
###begin title 32
Site directed mutational analysis of the RMKKK sequence
###end title 32
###begin p 33
###xml 203 206 203 206 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ala</underline>
###xml 215 218 215 218 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</underline>
###xml 250 253 250 253 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ala</underline>
###xml 268 271 268 271 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</underline>
###xml 312 315 312 315 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</underline>
###xml 318 321 318 321 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</underline>
The RMKKK sequence of syndecan-1 corresponding to Arg - Met -Lys - Lys - Lys was subjected to site directed mutagenesis by GenScript Corporation (NJ, USA) to generate three mutants. These were mutant 1, Ala - Met - Leu - Lys - Lys (AMLKK); mutant 2, Ala - Met - Lys - Leu - Lys (AMKLK); and mutant 3, Arg - Met -Leu - Leu - Lys (RMLLK).
###end p 33
###begin p 34
Cells were transfected with the RMKKK construct, or the mutants 1-3, according to the transfection protocol described above, and their fate was subsequently followed by confocal laser microscopy.
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
Sub-cellular localization of syndecan-1, heparanase, FGF-2 and FGFR-1
###end title 36
###begin p 37
###xml 210 228 210 228 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B, E and H</bold>
###xml 210 228 210 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g001"><bold>Figure 1B, E and H</bold></xref>
###xml 488 496 488 496 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</bold>
###xml 488 496 488 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g001"><bold>Figure 1</bold></xref>
###xml 498 507 498 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007346.s001">Figure S1</xref>
###xml 496 507 496 507 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, <xref ref-type="supplementary-material" rid="pone.0007346.s001">Figure S1</xref></bold>
###xml 621 630 621 630 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A</bold>
###xml 621 630 621 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g001"><bold>Figure 1A</bold></xref>
###xml 703 712 703 712 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 703 712 703 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g001"><bold>Figure 1C</bold></xref>
###xml 732 741 732 741 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1G</bold>
###xml 732 741 732 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g001"><bold>Figure 1G</bold></xref>
###xml 798 810 798 810 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1H, I</bold>
###xml 798 810 798 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g001"><bold>Figure 1H, I</bold></xref>
###xml 882 891 882 891 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 882 891 882 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g001"><bold>Figure 1D</bold></xref>
###xml 1059 1071 1059 1071 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1E, F</bold>
###xml 1059 1071 1059 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g001"><bold>Figure 1E, F</bold></xref>
###xml 1362 1373 1362 1373 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1J-L</bold>
###xml 1362 1373 1362 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g001"><bold>Figure 1J-L</bold></xref>
The sub-cellular distributions of syndecan-1, heparanase, FGF-2 and FGFR-1 were examined by immunocytochemistry. Syndecan-1 showed maximal intensity in the cell nuclei, nucleoli and/or in the perinuclear area (Figure 1B, E and H, respectively). The relative distribution of syndecan-1 between these locations, however, varied somewhat. Apart from the nuclear reactivity, cytoplasmic and cell membrane staining at the cell-cell contact sites were also clearly detected in malignant cells (Figure 1, Figure S1). Double staining with antibody specific for FGF-2 revealed similar distinct nuclear and nucleolar reactivities (Figure 1A). The nuclear reactivity of FGF-2 and syndecan-1 strictly co-localized (Figure 1C). Also heparanase (Figure 1G) showed co-localization with syndecan-1 in the nucleus (Figure 1H, I), suggesting the presence of a functional entity. In contrast, FGFR-1 (Figure 1D), known to form signaling complexes with FGF-2, was found only in the cytoplasm with maximal intensity in the perinuclear area, where it co-localized with syndecan-1 (Figure 1E, F). Notably, there was no FGFR-1 reactivity present in the nucleus of mesothelioma cells. The staining intensity at these locations varied, but the staining pattern was reproducible. The cells only displayed background levels of fluorescence when stained with corresponding isotype controls (Figure 1J-L).
###end p 37
###begin title 38
FGF-2 and heparanase, but not FGFR-1 co-localize with syndecan-1 in the nuclear compartment of mesothelioma cells.
###end title 38
###begin p 39
###xml 580 583 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bar</italic>
###xml 589 595 589 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> &#181;</italic>
###xml 678 686 674 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007346-t001">Tables 1</xref>
###xml 691 692 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007346-t002">2</xref>
Immunocytochemical staining of the STAV-AB cells for FGF-2 (A) or syndecan-1 (B) showed distinct nuclear and nucleolar localization. Merged images revealed a complete co-localization of FGF-2 and syndecan-1 (C) inside the nuclear envelope. FGFR-1 showed prominent perinuclear staining (D), and syndecan-1 (E) showed only a partial co-localization with FGFR-1 in the perinuclear area (F). Strong nuclear reactivity was also detected for heparanase (G), and syndecan-1 (H), with a clear nuclear co-localization (I). The corresponding isotype controls are shown as (J), (K) and (L). Bar  = 10 microm. Antibodies used: (A) 3+ III. (B) and (E) 2+ II. (D) 5+ IV. (G) 8+ VII. (H) 1+I (Tables 1 and 2).
###end p 39
###begin p 40
###xml 392 400 392 400 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</bold>
###xml 392 400 392 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g002"><bold>Figure 2</bold></xref>
Crude nuclear extracts from these cells also showed immunoreactivity to both syndecan-1 and FGF-2. The latter was increased considerably, following upregulation of syndecan-1 by transfection (data not shown). When syndecan-1 was specifically immunoprecipitated, FGF-2 was also found in the precipitate. The amount of co-precipitated nuclear FGF-2 increased when syndecan-1 was overexpressed (Figure 2), demonstrating that syndecan-1 is needed for this nuclear translocation.
###end p 40
###begin title 41
Syndecan-1 and FGF-2 co-immunoprecipitate in the nucleus of the STAV-AB cells.
###end title 41
###begin p 42
###xml 191 212 191 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
Co-IP and immunoblotting were performed on nuclear extracts of sub-confluent cultures of the STAV-AB cells, stably transfected with syndecan-1/EGFP construct or EGFP vector, as described in "Materials and Methods". Nuclear extract (100 microg) was incubated with 3 microg of syndecan-1 antibody, or with no antibody (negative control). The nuclear precipitates from equal amounts of control and sample proteins were slot-blotted onto a nitrocellulose membrane and then probed with antibody to FGF-2. A crude nuclear extract from syndecan-1/EGFP transfected cells was used as positive control. Co-IP using a specific antibody to syndecan-1 also pulled down FGF-2, as compared to the negative control. The amount of FGF-2 was higher in nuclear extracts from syndecan-1 overexpressing cells, compared to the EGFP control.
###end p 42
###begin title 43
Effect of drugs interfering with microtubule assembly and cell cycle progression on the nuclear translocation of syndecan-1
###end title 43
###begin p 44
###xml 131 142 131 142 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A&#8211;C</bold>
###xml 131 142 131 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g003"><bold>Figure 3A&#8211;C</bold></xref>
###xml 224 233 224 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007346.s002">Figure S2</xref>
###xml 224 233 224 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0007346.s002">Figure S2</xref></bold>
###xml 288 297 288 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 288 297 288 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g003"><bold>Figure 3A</bold></xref>
###xml 315 324 315 324 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3B</bold>
###xml 315 324 315 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g003"><bold>Figure 3B</bold></xref>
###xml 616 625 616 625 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3C</bold>
###xml 616 625 616 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g003"><bold>Figure 3C</bold></xref>
###xml 944 945 944 945 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1198 1207 1198 1207 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3E</bold>
###xml 1198 1207 1198 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g003"><bold>Figure 3E</bold></xref>
###xml 1291 1300 1291 1300 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D</bold>
###xml 1291 1300 1291 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g003"><bold>Figure 3D</bold></xref>
Treatment with vinblastine resulted in depolymerization of tubulin, which then precipitated into paracrystalline inclusion bodies (Figure 3A-C), whereas untreated cells showed the characteristic fibrillar tubulin structure (Figure S2). Double labeling experiments showed that both FGF-2 (Figure 3A) and syndecan-1 (Figure 3B) strictly co-localized with the depolymerized tubulin; furthermore, that tubulin depolymerization completely hampered the nuclear translocation of both syndecan-1 and FGF-2. In contrast, FGFR-1 was not associated with tubulin, and its distribution was not affected by vinblastine treatment (Figure 3C). FGFR-1 and tubulin had distinct cytoplasmic localization and were completely independent of each other. These results show that the transport route of FGFR-1 differs from that of syndecan-1 and FGF-2, which both associate and co-precipitate with the depolymerized tubulin. Doxorubicin, known to arrest cells in the G2 phase of the cell cycle, almost completely inhibited the nuclear transport of syndecan-1. When cells were exposed to doxorubicin from the time of cell seeding, sporadic weak nuclear syndecan-1 staining could be observed in single scattered cells only (Figure 3E). In contrast, the untreated cells showed distinct nuclear staining of syndecan-1 (Figure 3D).
###end p 44
###begin title 45
Effects of drugs interfering with microtubule assembly and cell cycle progression.
###end title 45
###begin p 46
###xml 209 224 209 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yellow crystals</italic>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">green</italic>
###xml 296 299 296 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
###xml 320 323 320 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
###xml 392 407 392 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yellow crystals</italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">green</italic>
###xml 466 469 466 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
The sub-cellular localizations of FGF-2 (A), syndecan-1 (B) and FGFR-1 (C) in the STAV-AB cells were detected after depolymerization of tubulin by vinblastine shown as co-localized paracrystalline structures (yellow crystals). Double staining was performed with tubulin (green) and either FGF-2 (red) (A) or syndecan-1 (red) (B), and both revealed strict co-localization of these components (yellow crystals, A, B). No co-localization of FGFR-1 (green) and tubulin (red) is detected (C), indicating a different transport route. Untreated STAV-FCS mesothelioma cells showed strong nuclear reactivity for syndecan-1 (D). Doxorubicin almost completely inhibited the nuclear transport of syndecan-1 in these cells (E).
###end p 46
###begin title 47
The sub-cellular localization of exogenous FGF-2
###end title 47
###begin p 48
###xml 348 357 348 357 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 348 357 348 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g004"><bold>Figure 4A</bold></xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Brockstedt1">[15]</xref>
###xml 519 528 519 528 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 519 528 519 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g004"><bold>Figure 4B</bold></xref>
In order to see whether externally administered FGF-2 would translocate to the nucleus via a tubulin-syndecan-1 mediated transport route, Alexa-labeled FGF-2 was added exogenously to the cell cultures. The intracellular distribution of Alexa-labeled FGF-2 was restricted to the cytoplasm of mesothelioma STAV-AB cells up to 42 hours after seeding (Figure 4A). This time scale was chosen based on our previous observation on the time course of the nuclear translocation of syndecan-1 [15]. In parallel, double staining (Figure 4B) revealed a substantial pool of endogenous FGF-2 in the nucleus, whereas syndecan-1 remained cytoplasmic.
###end p 48
###begin title 49
The sub-cellular localization of exogenously added FGF-2 differs from that of endogenous FGF2.
###end title 49
###begin p 50
###xml 234 239 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">green</italic>
###xml 277 280 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
In the STAV-AB cells, no nuclear accumulation of exogenously added Alexa 488-labeled FGF-2 could be observed 42 hours after seeding (A). In parallel, immunocytochemical staining (B) showed the presence of an endogenous pool of FGF-2 (green) in the nucleus, whereas syndecan-1 (red) remained cytoplasmic at this time point.
###end p 50
###begin title 51
Transport route and sub-cellular localization of newly synthesized syndecan-1
###end title 51
###begin p 52
###xml 175 183 175 183 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5</bold>
###xml 175 183 175 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g005"><bold>Figure 5</bold></xref>
###xml 288 296 288 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6</bold>
###xml 288 296 288 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g006"><bold>Figure 6</bold></xref>
The newly synthesized syndecan-1/EGFP and RMKKK/EGFP fusion proteins revealed signals of varying intensity and distinct sub-cellular distributions by fluorescence microscopy (Figure 5). The specificity of the signal was confirmed by immunocytochemical staining, using the CD138 antibody (Figure 6), which specifically recognizes the extracellular domain of syndecan-1, and verifies that functional syndecan-1 is being synthesized.
###end p 52
###begin title 53
Schematic representation and sub-cellular localization of the syndecan-1/EGFP fusion proteins.
###end title 53
###begin p 54
###xml 547 558 547 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left column</italic>
###xml 640 653 640 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">middle column</italic>
###xml 776 788 776 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right column</italic>
The whole syndecan-1 molecule was fused to EGFP, whereas the truncated RMKKK/EGFP construct contained only the tubulin binding RMKKK motif, which acts as a nuclear localization signal. The figure indicates where in the cytoplasmic domain of syndecan-1 the RMKKK sequence is located (A). The sub-cellular localization of the syndecan-1/EGFP fusion proteins, after transfection into the B6FS cells were detected by fluorescence microscopy (B). EGFP-transfected control cells revealed only cytoplasmic reactivity at various time points (24-72 h) (B, left column). Distinct nuclear localization was seen in the RMKKK/EGFP transfected cells (B, middle column), whereas the syndecan-1/EGFP fusion protein revealed faint nuclear, cytoplasmic and focal cell membrane reactivities (B, right column).
###end p 54
###begin title 55
Immunocytochemical detection of the syndecan-1 ectodomain and HS chains in syndecan-1/EGFP transfectants.
###end title 55
###begin p 56
###xml 292 293 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 566 569 562 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bar</italic>
###xml 238 243 <span type="species:ncbi:10090">Mouse</span>
###xml 273 277 <span type="species:ncbi:9925">Goat</span>
###xml 283 288 <span type="species:ncbi:10090">mouse</span>
###xml 341 346 <span type="species:ncbi:10090">mouse</span>
###xml 387 391 <span type="species:ncbi:9925">Goat</span>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
In the STAV-AB mesothelioma cells, cell membrane EGFP fluorescence appeared only in scattered cells 48 hours after transfection with syndecan-1/EGFP construct (A, D). The immunocytochemical detection of the syndecan-1 ectodomain (CD-138, Mouse monoclonal IgG1, detected by Goat anti-mouse IgG1 Alexa 568) is shown in (B), and the HS chains (mouse monoclonal IgM, clone 10E4, detected by Goat alpha-mouse IgM Alexa 568) in (E). The syndecan-1/EGFP fusion protein co-localized with the total amount of syndecan-1(C) and to some extent with the total amount of HS (F). Bar  = 20 microm.
###end p 56
###begin p 57
###xml 345 354 345 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 345 354 345 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g005"><bold>Figure 5B</bold></xref>
###xml 543 552 543 552 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 543 552 543 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g005"><bold>Figure 5B</bold></xref>
###xml 718 727 718 727 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 718 727 718 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g005"><bold>Figure 5B</bold></xref>
###xml 880 889 880 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007346.s003">Figure S3</xref>
###xml 880 889 880 889 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0007346.s003">Figure S3</xref></bold>
###xml 992 1004 992 1004 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6A, D</bold>
###xml 992 1004 992 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g006"><bold>Figure 6A, D</bold></xref>
###xml 1071 1083 1071 1083 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6B, C</bold>
###xml 1071 1083 1071 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g006"><bold>Figure 6B, C</bold></xref>
###xml 1362 1373 1362 1373 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6D&#8211;F</bold>
###xml 1362 1373 1362 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g006"><bold>Figure 6D&#8211;F</bold></xref>
In the transfected B6FS cells, detectable amount of syndecan-1/EGFP fluorescence was seen already 6 hours after transfection, and the expression pattern changed over time. Cytoplasmic fluorescence was seen at all time points, but after 6-12 hours there was a clear perinuclear accumulation and after 24 hours syndecan-1 appeared in the nucleus (Figure 5B). Notably, the most prominent nuclear signal was obtained with the RMKKK/EGFP sequence, suggesting that this pentapeptide may act as a putative nuclear localization signal for syndecan-1 (Figure 5B). Such nuclear localization appeared in approximately 60% of the transfected cells, whereas no nuclear localization was observed in the corresponding EGFP controls (Figure 5B). Similar sub-cellular distribution was also seen in the other studied cell types, i.e. the STAV-AB and STAV-FCS malignant mesothelioma cell sub-lines (Figure S3). Accumulation of syndecan-1/EGFP in the cell membrane could only be observed in few scattered cells (Figure 6A, D). The EGFP fluorescence coincided with the syndecan-1 ectodomain (Figure 6B, C). Furthermore, cell surface reactivity to HS could be detected by the 10E4 antibody in the syndecan-1/EGFP transfected cells. HS co-localized with EGFP florescence at the cell membrane, revealing that the newly synthesized syndecan-1/EGFP fusion protein also carried HS chains (Figure 6D-F).
###end p 57
###begin title 58
Mutational analysis of the RMKKK sequence
###end title 58
###begin p 59
###xml 52 55 52 55 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ala</underline>
###xml 52 55 52 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>Ala</underline></bold>
###xml 64 67 64 67 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</underline>
###xml 64 67 64 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>Leu</underline></bold>
###xml 101 104 101 104 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ala</underline>
###xml 101 104 101 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>Ala</underline></bold>
###xml 119 122 119 122 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</underline>
###xml 119 122 119 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>Leu</underline></bold>
###xml 303 311 303 311 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7</bold>
###xml 303 311 303 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g007"><bold>Figure 7</bold></xref>
###xml 555 558 555 558 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</underline>
###xml 555 558 555 558 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>Leu</underline></bold>
###xml 561 564 561 564 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</underline>
###xml 561 564 561 564 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>Leu</underline></bold>
In cells transfected to express the RMKKK mutant 1 (Ala - Met - Leu - Lys - Lys, AMLKK) or mutant 2 (Ala - Met - Lys - Leu - Lys, AMKLK), both containing alanine instead of arginine, the proportion of cells with a nuclear positivity for EGFP signal was reduced by up to 50% compared to wide type RMKKK (Figure 7). These EGFP fusion proteins were evenly distributed over the entire cell, without accumulation in any sub-cellular compartment. The replacement of two of the three lysines with leucines, but retention of the arginine, in mutant 3 (Arg - Met -Leu - Leu - Lys, RMLLK), did not significantly affect the nuclear localization. These results indicate the essential role of the arginine residue for the nuclear translocation of the RMKKK motif.
###end p 59
###begin title 60
Site directed mutational analysis of the RMKKK sequence in B6FS cells.
###end title 60
###begin p 61
Mutants 1 and 2, but not mutant 3 showed a significant decrease in the proportion of cells with nuclear localization of the respective EGFP construct, when compared to the wild type RMKKK transfectants. Asterisks denote a statistically significant difference from RMKKK. Error bars show standard errors of the mean (SEM) of three independent experiments. Mutations are highlighted in color in the scheme of the mutants.
###end p 61
###begin title 62
Discussion
###end title 62
###begin p 63
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Dobra1">[35]</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Zong1">[36]</xref>
###xml 634 638 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Brockstedt1">[15]</xref>
Malignant mesothelioma and fibrosarcoma are aggressive tumors of mesenchymal origin, and they express a characteristic PG profile, in which syndecan-2 and -4 are the main cell-surface PGs [35], [36]. Syndecan-1 is less abundant at the surface of mesothelioma cells, and the most prominent syndecan-1 reactivity is seen in the nucleus and in the mitotic spindle during mitosis. Moreover, the accumulation of syndecan-1 in the nucleus is tubulin-dependent and precedes the cell membrane reactivity, which is seen later when the culture becomes confluent. This phenomenon has been observed in a series of both benign and malignant cells [15].
###end p 63
###begin p 64
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Joy1">[25]</xref>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Maher1">[26]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Stachowiak1">[27]</xref>
###xml 496 500 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Stachowiak2">[39]</xref>
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Roghani1">[24]</xref>
###xml 625 629 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Hsia1">[40]</xref>
The co-localization of syndecan-1 with heparanase in cell nuclei suggests a simultaneous mechanism for the turnover of HS, indicating a regulatory importance of the nuclear syndecan-1. Similar nuclear accumulation occurs for growth factors, in particular FGF-2. In the mesothelioma cells we could detect a nuclear pool of syndecan-1 and FGF-2, whereas FGFR-1 remained exclusively perinuclear. In contrast to other cell types, this receptor never reached the nuclear compartment [25], [26], [27], [39]. Our results not only add to the growing literature showing a HS-mediated mechanism of nuclear translocation of FGF-2 [24], [40], but also identify a tubulin-mediated transport route for both syndecan-1 and FGF-2.
###end p 64
###begin p 65
###xml 159 167 159 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</bold>
###xml 159 167 159 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g002"><bold>Figure 2</bold></xref>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Zong1">[36]</xref>
###xml 839 851 839 851 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A, B</bold>
###xml 839 851 839 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g003"><bold>Figure 3A, B</bold></xref>
###xml 1085 1094 1085 1094 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 1085 1094 1085 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g001"><bold>Figure 1D</bold></xref>
###xml 1153 1162 1153 1162 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3C</bold>
###xml 1153 1162 1153 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g003"><bold>Figure 3C</bold></xref>
Immunoprecipitation experiments indicate that the co-localization of FGF-2 with syndecan-1 is associated with a physical interaction between the two proteins (Figure 2). We have recently proved by FACS analysis that syndecan-1 protein levels are increased 2-3 fold in these stable transfectants [36]. Our present data show that by overexpressing syndecan-1 the amount of nuclear FGF-2 increased approximately 2-fold, which provides evidence that syndecan-1 is needed for the nuclear transport of FGF-2. The presence of a greater amount of FGF-2 in the crude nuclear extract indicates that only part of the nuclear FGF-2 is bound to syndecan-1. This finding suggests that there also are other syndecan-1 independent routes for FGF-2 transport to the nucleus. Tubulin depolymerization prevents the nuclear transport of FGF-2 and syndecan-1 (Figure 3A, B), and the fact that both components co-localize with the depolymerized tubulin indicates stable associations between them. They thus seem to share a common tubulin-dependent transport mechanism. In contrast, no nuclear localization (Figure 1D) or co-localization with tubulin was observed for FGFR-1 (Figure 3C) pointing toward a divergent transport route for this molecule.
###end p 65
###begin p 66
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Brockstedt1">[15]</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Boulikas1">[41]</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Hodel1">[42]</xref>
###xml 703 706 703 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Tkachenko1">[3]</xref>
###xml 868 876 868 876 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5</bold>
###xml 868 876 868 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g005"><bold>Figure 5</bold></xref>
###xml 1400 1408 1400 1408 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7</bold>
###xml 1400 1408 1400 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g007"><bold>Figure 7</bold></xref>
We have previously shown nuclear syndecan-1 in many other cell types besides malignant mesothelioma, including benign mesothelial cells, normal dermal fibroblasts, endothelial cells, adenocarcinomas and neuroblastoma cells [15]. In the present study, we show that the cytoplasmic RMKKK sequence of syndecan-1 is acting as a nuclear localization signal. This sequence corresponds to the characteristic short sequence of positively charged amino acids like lysine (K) and arginine (R) that defines a nuclear protein [41], [42]. It is located in the highly conserved C1 domain of syndecan-1, also known to be involved in the linkage to several cytoskeletal proteins, including tubulin, cortactin and ezrin [3]. Our findings show that this short motif of syndecan-1 is both necessary and sufficient for the nuclear translocation of a protein, as shown here fused to EGFP (Figure 5). Transfection with the RMKKK/EGFP construct results in a rapid accumulation of the fusion protein in the cell nucleus, whereas no such nuclear accumulation is observed in the control EGFP-transfected cells. Furthermore, replacement of the one arginine is sufficient to substantially decrease the nuclear accumulation of the mutated fusion proteins. The mutants 1 and 2 share a common arginine mutation and give a dramatic decrease of nuclear translocation, which indicates that arginine is most crucial for this function (Figure 7). However, the syndecan-1/EGFP construct, carrying the EGFP on the cytoplasmic tail, translocated to the nucleus much less efficiently than the native syndecan-1 or the RMKKK/EGFP construct. This indicates that the C-terminal region of syndecan-1 is important for the tubulin-mediated nuclear transport.
###end p 66
###begin p 67
###xml 203 211 203 211 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6</bold>
###xml 203 211 203 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g006"><bold>Figure 6</bold></xref>
###xml 404 409 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Chen1">[43]</xref>
The EGFP fluorescence co-localizes both with newly synthesized syndecan-1 protein and HS at the cell membrane, revealing that the newly synthesized syndecan-1/EGFP fusion protein also carries HS chains (Figure 6), which is important for its GF binding capacity. To what extent the HS chains are themselves important for the nuclear translocation process is still an open and challenging question. Chen L et al have recently shown that heparanase overexpression or addition of recombinant heparansae decreases the nuclear syndecan-1 in a concentration-dependent manner, suggesting that the translocation is dependent to a significant extent upon the HS chains [43].
###end p 67
###begin p 68
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Jans1">[44]</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Sperinde1">[45]</xref>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Keresztes1">[46]</xref>
###xml 728 732 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Kolset1">[47]</xref>
###xml 998 1007 998 1007 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 998 1007 998 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g004"><bold>Figure 4A</bold></xref>
###xml 1311 1320 1311 1320 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 1311 1320 1311 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g004"><bold>Figure 4B</bold></xref>
It has been suggested that the interaction of syndecan-1 with GFs on the cell surface may assist the internalization and intracellular trafficking of these factors. This mechanism is not completely elucidated, but several lines of evidence indicate the importance of HSPG in this process. Furthermore, GFs like FGF-2 and PDGF can act by triggering second messenger systems in addition to their effects on gene transcription [44]. Studies show that internalized FGF-2 survives longer periods of time in cells expressing HSPGs than in HSPG-deficient cells [45]. The majority of GF/GFR complexes on the cell surface get internalized and degraded in lysosomes, perhaps as part of the receptor-turnover pathway (for review see [46], [47]). The HSPG/GF complex might serve as a reservoir for GFs protecting them from degradation and allowing later entrance into the nucleus. However, such transport of exogenous FGF-2 from the cell surface to the nucleus could not be verified in the mesothelioma cells (Figure 4A). The finding that exogenously added GF never reached the nucleus in detectable amounts, contradicts the idea that this is a major route for FGF-2 present in the nucleus. In contrast, a substantial pool of endogenous FGF-2 is detected in the nucleus at the same time point by a parallel immunostaining (Figure 4B), suggesting an independent intracrine route, besides a tubulin/syndecan-1 mediated nuclear translocation.
###end p 68
###begin p 69
###xml 175 183 175 183 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</bold>
###xml 175 183 175 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007346-g002"><bold>Figure 2</bold></xref>
Overexpression of syndecan-1 increased the amount of the nuclear FGF-2 in the crude nuclear extract and also co-immunoprecipitated together with the ectodomain of syndecan-1 (Figure 2), thereby emphasizing the role of syndecan-1 for this nuclear translocation.
###end p 69
###begin p 70
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Brockstedt1">[15]</xref>
Whether syndecan-1 follows an intracrine route or passes the cell membrane can not be answered from the present experimental results. The fact that syndecan-1 is seen in the nucleus before it accumulates in the cell membrane [15] to some extent supports the hypothesis of an intracrine loop. Since there is a strict co-localization of both N- and C-terminal portions of the syndecan-1 core protein with the HS side chains, the nuclear syndecan-1 seems to be the entire HSPG, which therefore must have been processed by the Golgi apparatus for HS modification before being transported to the nucleus.
###end p 70
###begin p 71
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007346-Brockstedt1">[15]</xref>
It is plausible that this PG may be directed to different cellular compartments at different situations. Syndecan-1 gives faint immunocytochemical staining at the cell surface of the mesothelioma cells, detectable amounts being seen only at cell confluence. It may be that in the confluent cultures the shedding of syndecan-1 decreases, allowing it to accumulate on the cell surface [15]. The finding that FGF-2 and syndecan-1 often, but not always, co-localize in the nucleus, and that their expression levels vary during the experiments, also leaves the possibility of alternative routes for the nuclear translocation of these two components. This variability may also depend on a dynamic molecular switch consisting of subsequent association and dissociation events, where the activity of the HS moieties is modulated by the co-localizing heparanase. Once in the nucleus, however, syndecan-1 may well bind GFs, as shown by their tight co-localization. Furthermore, the activity of the heparanase may counteract the formation of GFs/syndecan-1 complexes, thereby regulating their possible functions.
###end p 71
###begin p 72
The presence of syndecan-1 inside the nucleus raises many challenging questions remaining to be elucidated, including the nuclear targets of syndecan-1 and their possible downstream effects. Studies on such effects of nuclear syndecan-1 have been initiated in our laboratory.
###end p 72
###begin title 73
Supporting Information
###end title 73
###begin p 74
Characteristic staining pattern of syndecan-1 in malignant cells. Immunocytochemical staining of syndecan-1 by CD138 antibody was performed in MCF-7 breast cancer (A, B), WART adenocarcinoma (C) and HTB-11 neuroblastoma (D) cells. Distinct nuclear syndecan-1 reactivity was seen in all cells. In addition to nuclear staining, a prominent perinuclear staining was seen in (B), distinct cell membrane staining at the cell-cell contact sites in (C), and cytoplasmic and cell membrane positivity in (D).
###end p 74
###begin p 75
(1.48 MB TIF)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
###xml 153 158 <span type="species:ncbi:10090">mouse</span>
###xml 244 248 <span type="species:ncbi:9925">goat</span>
###xml 254 259 <span type="species:ncbi:10090">mouse</span>
Tubulin structure in the mesothelioma cells. Sub-confluent the STAV-AB malignant mesothelioma cells were stained with primary antibody to alpha-tubulin (mouse monoclonal IgG1, Sigma T5168), and detected by green fluorescent secondary antibody (goat anti-mouse IgG (H+L), F(ab')2 Alexa 488, Molecular Probes A11017). Typical fibrillar tubulin structure was seen in the mesothelioma cells without vinblastine treatment.
###end p 77
###begin p 78
(0.59 MB TIF)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
Sub-cellular localization of syndecan-1/EGFP fusion proteins in the STAV-AB and STAV-FCS mesothelioma cell lines. The EGFP-transfected control cells displayed only cytoplasmic reactivity at various time points (24-72 h) (left column). Distinct nuclear localization was seen in the RMKKK/EGFP transfected cells (middle column), whereas the syndecan-1/EGFP fusion protein revealed faint nuclear, cytoplasmic and focal cell membrane reactivities (right column).
###end p 80
###begin p 81
(0.83 MB TIF)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
The authors acknowledge Prof. I. Vlodavsky (Haifa, Israel) for kindly providing the polyclonal heparanase antibody.
###end p 83
###begin title 84
References
###end title 84
###begin article-title 85
Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions.
###end article-title 85
###begin article-title 86
Functions of cell surface heparan sulfate proteoglycans.
###end article-title 86
###begin article-title 87
Syndecans: new kids on the signaling block.
###end article-title 87
###begin article-title 88
Syndecans in tumor cell adhesion and signaling.
###end article-title 88
###begin article-title 89
Function of the syndecans - a family of cell surface proteoglycans.
###end article-title 89
###begin article-title 90
Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.
###end article-title 90
###begin article-title 91
Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation.
###end article-title 91
###begin article-title 92
Interaction of heparan sulfate from mammary cells with acidic fibroblast growth factor (FGF) and basic FGF. Regulation of the activity of basic FGF by high and low affinity binding sites in heparan sulfate.
###end article-title 92
###begin article-title 93
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.
###end article-title 93
###begin article-title 94
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.
###end article-title 94
###begin article-title 95
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
###end article-title 95
###begin article-title 96
Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis.
###end article-title 96
###begin article-title 97
Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans.
###end article-title 97
###begin article-title 98
Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
###end article-title 98
###begin article-title 99
Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: tubulin dependent rearrangements.
###end article-title 99
###begin article-title 100
###xml 52 57 <span type="species:ncbi:9606">human</span>
Heparin and its non-anticoagulant analogues inhibit human keratinocyte growth without inducing differentiation.
###end article-title 100
###begin article-title 101
Correlations between heparan sulfate metabolism and hepatoma growth.
###end article-title 101
###begin article-title 102
Control of cell division in hepatoma cells by exogenous heparan sulfate proteoglycan.
###end article-title 102
###begin article-title 103
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 124 129 <span type="species:ncbi:9606">human</span>
Differences in the uptake and nuclear localization of anti-proliferative heparan sulfate between human lung fibroblasts and human lung carcinoma cells.
###end article-title 103
###begin article-title 104
Regulation of heparan sulfate proteoglycan nuclear localization by fibronectin.
###end article-title 104
###begin article-title 105
###xml 170 173 <span type="species:ncbi:10116">rat</span>
Intracellular trafficking in neurones and glia of fibroblast growth factor-2, fibroblast growth factor receptor 1 and heparan sulphate proteoglycans in the injured adult rat cerebral cortex.
###end article-title 105
###begin article-title 106
Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma.
###end article-title 106
###begin article-title 107
Glypican and biglycan in the nuclei of neurons and glioma cells: presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle.
###end article-title 107
###begin article-title 108
Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms.
###end article-title 108
###begin article-title 109
###xml 66 71 <span type="species:ncbi:9606">human</span>
Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells.
###end article-title 109
###begin article-title 110
Nuclear Translocation of fibroblast growth factor (FGF) receptors in response to FGF-2.
###end article-title 110
###begin article-title 111
###xml 62 67 <span type="species:ncbi:9606">human</span>
Nuclear accumulation of fibroblast growth factor receptors in human glial cells-association with cell proliferation.
###end article-title 111
###begin article-title 112
Signaling, internalization, and intracellular activity of fibroblast growth factor.
###end article-title 112
###begin article-title 113
Fibroblast growth factor-2 binds to the regulatory beta subunit of CK2 and directly stimulates CK2 activity toward nucleolin.
###end article-title 113
###begin article-title 114
###xml 72 78 <span type="species:ncbi:9913">bovine</span>
Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells.
###end article-title 114
###begin article-title 115
Perinuclear localization of an intracellular binding protein related to the fibroblast growth factor (FGF) receptor 1 is temporally associated with the nuclear trafficking of FGF-2 in proliferating epiphyseal growth plate chondrocytes.
###end article-title 115
###begin article-title 116
Translocation of FGF-1 and FGF-2 across vesicular membranes occurs during G1-phase by a common mechanism.
###end article-title 116
###begin article-title 117
###xml 59 64 <span type="species:ncbi:9606">human</span>
Serum- dependent growth patterns of two, newly established human mesothelioma cell lines.
###end article-title 117
###begin article-title 118
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human neoplastic cells in tissue culture: two established cell lines derived from giant cell tumor and fibrosarcoma.
###end article-title 118
###begin article-title 119
Differentiation of mesothelioma cells is influenced by the expression of proteoglycans.
###end article-title 119
###begin article-title 120
Effect of Syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains
###end article-title 120
###begin article-title 121
###xml 62 67 <span type="species:ncbi:9606">human</span>
Immunocytochemical localization of glucocorticoid receptor in human gingival fibroblasts and evidence for a colocalization of glucocorticoid receptor with cytoplasmic microtubules.
###end article-title 121
###begin article-title 122
Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.
###end article-title 122
###begin article-title 123
Integrative nuclear FGFR1 signaling (INFS) as a part of a universal "feed-forward-and-gate" signaling module that controls cell growth and differentiation.
###end article-title 123
###begin article-title 124
Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling.
###end article-title 124
###begin article-title 125
Putative nuclear localization signals (NLS) in protein transcription factors.
###end article-title 125
###begin article-title 126
Dissection of a nuclear localization signal.
###end article-title 126
###begin article-title 127
Heparanase regulates levels of syndecan-1 in the nucleus.
###end article-title 127
###begin article-title 128
Nuclear targeting by growth factors, cytokines, and their receptors: a role in signaling?
###end article-title 128
###begin article-title 129
Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells.
###end article-title 129
###begin article-title 130
Import(ance) of growth factors in(to) the nucleus.
###end article-title 130
###begin article-title 131
Intracellular proteoglycans.
###end article-title 131
###begin p 132
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 132
###begin p 133
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was funded by grants from the Swedish Cancer Fund (56301053) and the Swedish Heart and Lung Association (56301033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 133

